SELECT (Recruiting) Evaluation of cardiovascular outcomes with semaglutide in patients with overweight or obesity and prior MI/stroke Medicine semaglutide Population Diabetes mellitus Phase III Starting year 2018 Director of Study dr. F.M.A.C. Martens (Cardioloog) Deventer, Deventer Ziekenhuis
